日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

CIIE helps Bristol Myers Squibb expand China footprint

By Cao Chen in Shanghai | chinadaily.com.cn | Updated: 2021-06-29 16:33
Share
Share - WeChat
Visitors make inquiries at the stand of Bristol-Myers Squibb during the second China International Import Expo in Shanghai on Nov 9, 2019. [Photo by Lyu Liang/For China Daily]

The China International Import Expo has been a major platform for US biopharmaceutical enterprise Bristol-Myers Squibb to bring its experience in immuno-oncology treatment to the Chinese market and showcase its scientific and innovative achievements, said Chen Siyuan, general manager of Bristol-Myers Squibb China and Hong Kong.

At the third expo held in Shanghai last year, the company unveiled its five-year strategy tailored to the domestic market. The strategy involves accelerating the introduction of nearly 30 innovative drugs to the market, increasing the number of employees in its R&D and commercial teams, growing its investment in China and introducing the latest product lines to China to benefit more patients.

The company also reached a series of agreements with local partners in China at the third CIIE, including a contract with domestic health platform JD Health to establish an online liver disease innovation platform that would improve accessibility of the drug Baraclude, which is used to treat hepatitis B infection of the liver.

Data shows the platform helped raise online sales of the drug, which accounted for 12.5 percent of the company's sales in the first quarter.

A strategic relationship also was established between the company and Hainan Boao Lecheng International Medical Tourism Pilot Zone in South China's Hainan province. According to this partnership, the company's latest products will be first made available in the zone.

The company attended the expo for the first time in 2019 and displayed an immunotherapy drug, Opdivo. According to the company, a Nobel Prize laureate contributed to the development of this drug.

Opdivo has since been approved for use in the treatment of lung cancer, head and neck cancer, and gastric cancer in China.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 84pao强力打造 | 国产成人理在线观看视频 | 色版网站 | 亚洲欧美一区二区三区在线 | 婷婷久久激情啪啪 | 私房色播 | 日韩高清不卡 | 午夜小视频网站 | 男人的午夜天堂 | 精品极品三级久久久久 | 综合二区 | 小明永久成人一区二区 | 一级黄色片在线 | 国产一区二区久久 | 免费看的黄色 | 久久无码人妻中文国产 | 欧美日韩一级视频 | 日韩精品久久久久久 | 欧美wwww | 五月综合久久 | 天天做天天爱天天大综合 | 日本中文在线 | 麻豆av在线播放 | 奇米影视小说 | 达达兔午夜起神影院在线观看麻烦 | 欧美日韩一区二区三区视频播 | 中文字幕成人av | 波多野结衣三级在线观看 | 亚洲精品久久婷婷丁香51 | 精品成人一区二区三区 | 一级视频片 | 一级黄色毛片播放 | 日韩一级片在线免费观看 | 免费的色网站 | 国产夜色福利院在线观看免费 | 亚洲第一页在线视频 | 黄色一级视频 | 玖玖福利| 色婷婷国产精品欧美毛片 | 日韩女同一区二区三区 | 亚洲天堂一区二区三区 |